About Christopher Shen
Form D filings for Nuvaira from 2019 to 2020 list Christopher Shen as director.
Form D filings also name Christopher Shen as a director at Moximed and Earlens.
Christopher Shen first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Shen in the role, so the role may have started earlier or lasted longer.
Nuvaira, Inc.
Director
2019 – 2020 · Minneapolis, MN
Develops a lung treatment device for people with chronic obstructive pulmonary disease.
Key Colleagues at Startups
The people Christopher Shen works with at each company, as listed on that company's latest Form D.
Nuvaira, Inc. · Form D, Jul 29, 2020
AS
Alexander Schmitz
Director
TH
Tim Herbert
Director
MC
Michael Carusi
Director
CN
Carolyn Ng
Director
Dennis Wahr
President & CEO, director
HP
Henry Plain
Director
JR
Jonathan Root
Director
Moximed, Inc · Form D, Mar 31, 2017
AF
Arthur Franken
Director
RA
Robert Anderson
Director
DM
Dan Murray
Chief Financial Officer
HP
Henry Plain
Director
RC
Robert Croce
Director
JM
Joshua Makower
Director
RD
Ryan Drant
Director
KS
Kevin Sidow
President/CEO and director
Earlens Corp · Form D, Jun 15, 2016
WF
William Facteau
Executive officer and director
SE
Steven Elms
Director
TP
Thomas Prescott
Director
JJ
Jeff Jones
Executive officer
AT
Art Taylor
Director
BE
Brent Edwards
Executive officer
GH
George Harter
Chief Financial Officer
CS
Cem Shaquer
Executive officer
BS
Bernard Shay
Executive officer
JB
Judy Brimacombe
Executive officer
PL
Phil Lyons
Executive officer
HJ
Henry Plain, Jr.
Director
BF
Bryan Flaherty
Executive officer
RD
Rodney Perkins, M.D.
Executive officer and director
MB
Mark Bishop
Executive officer
RD
Ryan Drant
Director
RC
Robert Croce
Director